Skip to main content

Treatment guidelines for acute bipolar depression

Bipolar depression is the facet of bipolar disorder most difficult to treat and responsible for most of the disability related to bipolar disorder. Despite supposedly being evidence-based, guidelines for the treatment of bipolar disorder vary significantly across committees or working groups. While the usefulness quetiapine, the olanzapine-fluoxetine combination, lithium, valproic and carbamazepine is widely accepted, it is clearly stated that in bipolar depression antidepressants should be used only in combination with antimanic agents in order to avoid switching of phases. However there is still controversy over the usefulness of the various agents and modalities mainly due to little and poor evidence and conflicting opinions.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Konstantinos N Fountoulakis.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Fountoulakis, K.N. Treatment guidelines for acute bipolar depression. Ann Gen Psychiatry 9, S63 (2010). https://doi.org/10.1186/1744-859X-9-S1-S63

Download citation

Keywords

  • Public Health
  • Lithium
  • Bipolar Disorder
  • Carbamazepine
  • Quetiapine